Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$58,188,336
+$14,390,311 QoQ
Shares Held
229,115
+27.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#411
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SATURNA CAPITAL CORP holds $1,106,352,364 across 8 Drug Manufacturers - General names. JNJ ranks #4 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
460,411 | $552,230,811 | |
| 2 | ABBV |
AbbVie Inc.
|
958,069 | $241,088,483 | |
| 3 | AZN |
Astrazeneca PLC
|
911,933 | $172,920,735 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
229,115 | $58,188,336 | |
| 5 | NVS |
Novartis AG
|
311,392 | $48,801,354 | |
| 6 | MRK |
Merck & Co., Inc.
|
197,643 | $25,397,125 | |
| 7 | NVO |
Novo Nordisk A S
|
116,291 | $5,574,990 | |
| 8 | GSK |
GSK plc
|
41,025 | $2,150,530 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,188,336 | 229,115 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $43,798,025 | 179,177 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $37,437,668 | 180,902 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $33,761,829 | 182,083 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,861,294 | 182,398 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $30,281,223 | 182,593 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $26,413,830 | 182,643 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $30,036,038 | 185,339 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $26,981,282 | 184,601 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $29,095,253 | 183,926 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $82,221,572 | 524,573 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $84,335,042 | 541,477 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $90,710,753 | 548,035 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $84,417,495 | 544,629 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $94,293,650 | 533,788 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $87,173,306 | 533,627 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $94,702,827 | 533,507 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $94,491,946 | 533,160 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $88,304,623 | 516,190 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $81,660,860 | 505,640 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $83,173,107 | 504,875 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $82,801,173 | 503,810 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $78,903,564 | 501,357 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $74,647,985 | 501,397 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $70,351,141 | 500,257 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $65,592,143 | 500,207 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||